Novavax Begins Midstage Study of COVID-19 Vaccine in South Africa Novavax Begins Midstage Study of COVID-19 Vaccine in South Africa
US drug developer Novavax said it started a midstage study of its experimental COVID-19 vaccine in South Africa, as the country experiences a surge in coronavirus cases.Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Family Medicine/Primary Care News Source Type: news
More News: African Health | Coronavirus | COVID-19 | Primary Care | South Africa Health | Study | Surgery | Vaccines